Moreover, KRAS_SIGNALING_DN has been associated with gastric and glioblastoma cancers (39, 40), and IL6_JAK_STAT3_SIGNALING is implicated in the progression of gliomas, bladder, and prostate cancers (41–43). This evidence concerns the gene IL6 and central nervous system cancer.